Name	Value
NAME	ONC2.210
DATE DISTRIBUTED	2020-04-21 00:00:00
PACKAGE FILE LINK	ONCOLOGY
REQUIRED BUILD	ONC2.211 ACTION: Don't install, leave global
TYPE	SINGLE PACKAGE
TRACK PACKAGE NATIONALLY	YES
FILE	DD NUMBER: ONCOLOGY SITE PARAMETERS (File-top level) FIELD NUMBER: COC ACCREDITATION TEXT UPDATE THE DATA DICTIONARY: YES SEND SECURITY CODE: YES SEND FULL OR PARTIAL DD: PARTIAL DATA COMES WITH FILE: NO MAY USER OVERRIDE DATA UPDATE: NO UPDATE THE DATA DICTIONARY: YES SEND SECURITY CODE: YES SEND FULL OR PARTIAL DD: FULL RESOLVE POINTERS: NO DATA COMES WITH FILE: YES SITE'S DATA: OVERWRITE MAY USER OVERRIDE DATA UPDATE: NO UPDATE THE DATA DICTIONARY: YES SEND SECURITY CODE: YES SEND FULL OR PARTIAL DD: FULL RESOLVE POINTERS: NO DATA COMES WITH FILE: YES SITE'S DATA: OVERWRITE MAY USER OVERRIDE DATA UPDATE: NO UPDATE THE DATA DICTIONARY: YES SEND SECURITY CODE: YES SEND FULL OR PARTIAL DD: FULL RESOLVE POINTERS: NO DATA COMES WITH FILE: YES SITE'S DATA: OVERWRITE MAY USER OVERRIDE DATA UPDATE: NO UPDATE THE DATA DICTIONARY: YES SEND SECURITY CODE: YES SEND FULL OR PARTIAL DD: FULL RESOLVE POINTERS: NO DATA COMES WITH FILE: YES SITE'S DATA: OVERWRITE MAY USER OVERRIDE DATA UPDATE: NO UPDATE THE DATA DICTIONARY: YES SEND SECURITY CODE: YES SEND FULL OR PARTIAL DD: FULL RESOLVE POINTERS: NO DATA COMES WITH FILE: YES SITE'S DATA: OVERWRITE MAY USER OVERRIDE DATA UPDATE: NO UPDATE THE DATA DICTIONARY: YES SEND SECURITY CODE: YES SEND FULL OR PARTIAL DD: FULL RESOLVE POINTERS: NO DATA COMES WITH FILE: YES SITE'S DATA: OVERWRITE MAY USER OVERRIDE DATA UPDATE: NO UPDATE THE DATA DICTIONARY: YES SEND SECURITY CODE: YES SEND FULL OR PARTIAL DD: FULL RESOLVE POINTERS: NO DATA COMES WITH FILE: YES SITE'S DATA: OVERWRITE MAY USER OVERRIDE DATA UPDATE: NO DD NUMBER: ONCOLOGY PRIMARY (File-top level) FIELD NUMBER: LYMPH-VASCULAR INVASION (L) SUMMARY STAGE 2018 EOD PRIMARY TUMOR EOD REGIONAL NODES EOD METS GRADE CLINICAL GRADE PATHOLOGICAL GRADE POST-THERAPY SEER SUMMARY STAGE 2000 SEER SSF1-HPV STATUS SCHEMA ID CHROMOSOME 1P: (LOH) CHROMOSOME 19Q: (LOH) ADENOID CYSTIC BASALOID PTTRN ADENOPATHY AFP POST-ORCHIECTOMY LAB VAL AFP POST-ORCHIECTOMY RANGE AFP PRE-ORCHIECTOMY LAB VALUE AFP PRE-ORCHIECTOMY RANGE AFP PRETREATMENT INTERPRET AFP PRETREATMENT LAB VALUE ANEMIA B SYMPTOMS BILIRUBIN PRE TOTAL LAB VALUE BILIRUBIN PRETREATMENT UNIT BONE INVASION BRAIN MOLECULAR MARKERS BRESLOW TUMOR THICKNESS CA-125 PRETREATMENT INTER CEA PRETREATMENT INTER CEA PRETREATMENT LAB VALUE CHROMOSOME 3 STATUS CHROMOSOME 8Q STATUS CIRCUMFERENTIAL RESECT MARGIN CREATININE PRETREAT LAB VALUE CREATININE PRETREAT UNIT ESTROGEN RECEPTOR RANGE ESTROGEN RECEPTOR SUMMARY ESTROGEN RECEPTOR TOTAL ALLRED ESOPHAGUS EGJ TUMOR EPICENTER ENE CLIN (NON-HEAD AND NECK) ENE HEAD AND NECK CLINICAL ENE HEAD AND NECK PATHOLOGICAL ENE PATH (NON-HEAD AND NECK) EXTRAVASCULAR MATRIX PATTERNS FIBROSIS SCORE FIGO STAGE GESTATIONAL TROPHOBLASTIC GLEASON PATTERNS CLINICAL GLEASON PATTERNS PATHOLOGICAL GLEASON SCORE CLINICAL GLEASON SCORE PATHOLOGICAL GLEASON TERTIARY PATTERN HCG POST-ORCHIECTOMY LAB VALUE HCG POST-ORCHIECTOMY RANGE HCG PRE-ORCHIECTOMY LAB VALUE HCG PRE-ORCHIECTOMY RANGE HER2 IHC SUMMARY HER2 ISH DUAL PROBE COPY NUM HER2 ISH DUAL PROBE RATIO HER2 ISH SINGLE PROBE COPY NUM HER2 ISH SUMMARY HER2 OVERALL SUMMARY HERITABLE TRAIT HIGH RISK CYTOGENETICS HIGH RISK HISTOLOGIC FEATURES HIV STATUS INR PROTHROMBIN TIME IPSILATERANL ADRENAL GLAND INV JAK2 KI-67 INVASION BEYOND CAPSULE KIT GENE IMMUNOHISTOCHEMISTRY KRAS LDH POST-ORCHIECTOMY RANGE LDH PRE-ORCHIECTOMY RANGE LDH PRETREATMENT LEVEL LDH UPPER LIMITS OF NORMAL LN ASSESS METH FEMORAL-INGUIN LN ASSESS METHOD PARA-AORTIC LN ASSESSMENT METHOD PELVIC LN DISTANT ASSESSMENT METHOD LN DISTANT MEDIASTINAL,SCALENE LN HEAD & NECK LEVELS I-III LN HEAD & NECK LEVELS IV-V LN HEAD & NECK LEVELS VI-VII LN HEAD AND NECK OTHER LN ISOLATED TUMOR CELLS (ITC) LN LATERALITY LN POSITIVE AXILLARY LVL I-II LN SIZE LN STATUS FEM-ING,PAR-AOR,PLV LYMPHOCYTOSIS MAJOR VEIN INVOLVEMENT MEASURED BASAL DIAMETER MEASURED THICKNESS METHYLATION OF MGMT MICROSATELLITE INSTABILITY MICROVASCULAR DENSITY MITOTIC COUNT UVEAL MELANOMA MITOTIC RATE MELANOMA MULTIGENE SIGNATURE METHOD MULTIGENE SIGNATURE RESULTS NCCN IPI NUMBER OF CORES EXAMINED NUMBER OF CORES POSITIVE NUM OF EXAMINED PARA-AORTIC NUM OF EXAMINED PELVIC NODES NUM OF POS PARA-AORTIC NODES NUM OF POSITIVE PELVIC NODES ONCOTYPE DX RECUR SCORE-DCIS ONCOTYPE DX REC SCORE-INVASIVE ONCOTYPE DX RISK LEVEL-DCIS ONCOTYPE DX RISK LEVEL-INVAS ORGANOMEGALY PERCENT NECROSIS PST NEOADJVNT PERINEURAL INVASION 2018 PERIPHERAL BLOOD INVOLV 2018 PERITONEAL CYTOLOGY PLEURAL EFFUSION PROGESTERONE RECEPTOR % POS PROGESTERONE RECEPTOR SUMMARY PROGESTERONE RCPTR ALLRED SCR PRIMARY SCLEROSING CHOLANGITIS PROFOUND IMMUNE SUPPRESSION PROSTATE PATHOLOGICAL EXT PSA LAB VALUE RESIDUAL TUM VOL PST CYTO RESPONSE TO NEOADJUVANT THERA S CATEGORY CLINICAL S CATEGORY PATHOLOGICAL SARCOMATOID FEATURES SCHEMA DISCRIMINATOR 1 SCHEMA DISCRIMINATOR 2 SCHEMA DISCRIMINATOR 3 SEPARATE TUMOR NODULES SERUM ALBUMIN PRETREAT VALUE SERUM BETA-2 MICROGLOBULIN LDH PRETREATMENT LAB VALUE THROMBOCYTOPENIA TUMOR DEPOSITS TUMOR GROWTH PATTERNS ULCERATION 2018 VISCERAL PARIETAL PLEURAL INV AJCC ID AJCC TNM CLIN T AJCC TNM CLIN N AJCC TNM CLIN M AJCC TNM CLIN STAGE GROUP AJCC TNM PATH T AJCC TNM PATH N AJCC TNM PATH M AJCC TNM PATH STAGE GROUP AJCC TNM POST THERAPY T AJCC TNM POST THERAPY N AJCC TNM POST THERAPY M AJCC TNM POST THERAPY STAGE GP AJCC TNM CLIN T SUFFIX AJCC TNM PATH T SUFFIX AJCC TNM POST THERAPY T SUFFIX AJCC TNM CLIN N SUFFIX AJCC TNM PATH N SUFFIX AJCC TNM POST THERAPY N SUFFIX PHASE I DOSE PER FRACTION PHASE I RAD EXT BEAM PLANNING PHASE I NUMBER OF FRACTIONS PHASE I RAD TREATMENT VOLUME PHASE I RAD TO DRAINING LN PHASE I RAD TREATMENT MODALITY PHASE I TOTAL DOSE PHASE II DOSE PER FRACTION PHASE II RAD EXT BEAM PLANNING PHASE II NUMBER OF FRACTIONS PHASE II RAD TREATMENT VOLUME PHASE II RAD TO DRAINING LN PHASE II RAD TREATMNT MODALITY PHASE II TOTAL DOSE PHASE III DOSE PER FRACTION PHASE III RAD EXT BEAM PLANNIN PHASE III NUMBER OF FRACTIONS PHASE III RAD TREATMENT VOLUME PHASE III RAD TO DRAINING LN PHASE III RAD TREATMT MODALITY PHASE III TOTAL DOSE STATE AT DX GEOCODE 1970/80/90 STATE AT DX GEOCODE 2010 BEHAVIOR (73-91) ICD-O-1 GRADE (73-91) ICD-O-1 RUCA 2000 RUCA 2010 URIC 2000 URIC 2010 DERIVED EOD 2018 T DERIVED EOD 2018 N DERIVED EOD 2018 M DERIVED EOD 2018 STAGE GROUP DERIVED SUMMARY STAGE 2018 DATE REGIONAL LN DISSECTION DATE REG LN DISSECTION FLAG SENTINEL LYMPH NODES POSITIVE SENTINEL LYMPH NODES EXAMINED DATE OF SENTINEL LN BIOPSY DATE OF SENTINEL LN BIOPSY FLG NPCR DERIVED AJCC8 CLN STG GRP NPCR DERIVED AJCC8 PTH STG GRP NPCR DERIVED AJCC8 PT STG GRP NPCR SPECIFIC FIELD STATE AT DX GEOCODE 2000 NUMBER OF PHASES RAD TX RADIATION TX DISCONTND EARLY TOTAL DOSE OVER-RIDE TNM STAGE OVER-RIDE TNM TIS OVER-RIDE TNM 3 OVER-RIDE NAME/SEX HISTOLOGY (73-91) ICD-O-1 RQRS NCDB SUBMISSION FLAG COC ACCREDITED FLAG VITAL STATUS RECODE RECORD NUMBER RECODE SEER CAUSE SPECIFIC COD SEER OTHER COD MEDICARE BENEFICIARY ID TUMOR STATUS (sub-file) FIELD NUMBER: DATE OF LAST CANCER STATUS DATE OF LAST CANCER STATUS FLG UPDATE THE DATA DICTIONARY: YES SEND SECURITY CODE: YES SEND FULL OR PARTIAL DD: PARTIAL DATA COMES WITH FILE: NO MAY USER OVERRIDE DATA UPDATE: NO UPDATE THE DATA DICTIONARY: YES SEND SECURITY CODE: YES SEND FULL OR PARTIAL DD: FULL RESOLVE POINTERS: NO DATA COMES WITH FILE: YES SITE'S DATA: OVERWRITE MAY USER OVERRIDE DATA UPDATE: NO UPDATE THE DATA DICTIONARY: YES SEND SECURITY CODE: YES SEND FULL OR PARTIAL DD: FULL RESOLVE POINTERS: NO DATA COMES WITH FILE: YES SITE'S DATA: OVERWRITE MAY USER OVERRIDE DATA UPDATE: NO UPDATE THE DATA DICTIONARY: YES SEND SECURITY CODE: YES SEND FULL OR PARTIAL DD: FULL RESOLVE POINTERS: NO DATA COMES WITH FILE: YES SITE'S DATA: OVERWRITE MAY USER OVERRIDE DATA UPDATE: NO UPDATE THE DATA DICTIONARY: YES SEND SECURITY CODE: YES SEND FULL OR PARTIAL DD: FULL RESOLVE POINTERS: NO DATA COMES WITH FILE: YES SITE'S DATA: OVERWRITE MAY USER OVERRIDE DATA UPDATE: NO UPDATE THE DATA DICTIONARY: YES SEND SECURITY CODE: YES SEND FULL OR PARTIAL DD: FULL RESOLVE POINTERS: NO DATA COMES WITH FILE: YES SITE'S DATA: OVERWRITE MAY USER OVERRIDE DATA UPDATE: NO UPDATE THE DATA DICTIONARY: YES SEND SECURITY CODE: YES SEND FULL OR PARTIAL DD: FULL RESOLVE POINTERS: NO DATA COMES WITH FILE: YES SITE'S DATA: OVERWRITE MAY USER OVERRIDE DATA UPDATE: NO UPDATE THE DATA DICTIONARY: YES SEND SECURITY CODE: YES SEND FULL OR PARTIAL DD: FULL RESOLVE POINTERS: NO DATA COMES WITH FILE: YES SITE'S DATA: OVERWRITE MAY USER OVERRIDE DATA UPDATE: NO
BUILD COMPONENTS	ENTRIES: ONCO ABSTRACT-I FILE #165.5 FILE: ONCOLOGY PRIMARY ACTION: SEND TO SITE ONCO RECURRENCE FOLLOWUP FILE #165.5 FILE: ONCOLOGY PRIMARY ACTION: SEND TO SITE ENTRIES: ONCODIS ACTION: SEND TO SITE CHECKSUM: B794969 ONCOPA1 ACTION: SEND TO SITE CHECKSUM: B60933311 ONCOPA1A ACTION: SEND TO SITE CHECKSUM: B73026178 ONCOPA2 ACTION: SEND TO SITE CHECKSUM: B64936187 ONCOU55 ACTION: SEND TO SITE CHECKSUM: B34003832 ONCPCI ACTION: SEND TO SITE CHECKSUM: B31602147 ONCPSD ACTION: SEND TO SITE CHECKSUM: B18760519 ONCPTX ACTION: SEND TO SITE CHECKSUM: B121243527 ONCSCHMA ACTION: SEND TO SITE CHECKSUM: B119267434 ONCSCHMB ACTION: SEND TO SITE CHECKSUM: B96210850 ONCSCHMC ACTION: SEND TO SITE CHECKSUM: B75257552 ONCEDIT ACTION: SEND TO SITE CHECKSUM: B58474803 ONCSCHMD ACTION: SEND TO SITE CHECKSUM: B115413496 ONCSCHME ACTION: SEND TO SITE CHECKSUM: B102239697 ONCSCHMG ACTION: SEND TO SITE CHECKSUM: B102038053 ONCSCHMP ACTION: SEND TO SITE CHECKSUM: B53442477 ONCSCHMS ACTION: SEND TO SITE CHECKSUM: B21992128 ONCSCHMT ACTION: SEND TO SITE CHECKSUM: B38607289 ONCSGA8A ACTION: SEND TO SITE CHECKSUM: B179981790 ONCSGA8B ACTION: SEND TO SITE CHECKSUM: B183119820 ONCSGA8C ACTION: SEND TO SITE CHECKSUM: B27848374 ONCSGA8H ACTION: SEND TO SITE CHECKSUM: B24138934 ONC2PSTN ACTION: SEND TO SITE CHECKSUM: B61873183 ONCSGA8U ACTION: SEND TO SITE CHECKSUM: B1746408 ONCSGA8X ACTION: SEND TO SITE CHECKSUM: B29958360 ONCOEDC1 ACTION: SEND TO SITE CHECKSUM: B51442697 ONCOEDC ACTION: SEND TO SITE CHECKSUM: B31599734 ONCOEDC2 ACTION: SEND TO SITE CHECKSUM: B26483375 ONCCS ACTION: SEND TO SITE CHECKSUM: B67320152 ONCOAIP2 ACTION: SEND TO SITE CHECKSUM: B119850739 ONCOSUR2 ACTION: SEND TO SITE CHECKSUM: B55357665 ONCSUBS ACTION: SEND TO SITE CHECKSUM: B7155078 ONCSCHMM ACTION: SEND TO SITE CHECKSUM: B35183618 ONCACD0 ACTION: SEND TO SITE CHECKSUM: B188212457 ONCSCHMU ACTION: SEND TO SITE CHECKSUM: B27105358 ONC2PS10 ACTION: SEND TO SITE CHECKSUM: B89627705 ONCOAIP ACTION: SEND TO SITE CHECKSUM: B132025583 ONCODSP ACTION: SEND TO SITE CHECKSUM: B56361354 ONCATF1 ACTION: SEND TO SITE CHECKSUM: B59347534 ONCSCHMY ACTION: SEND TO SITE CHECKSUM: B92368459 ONCSCHMX ACTION: SEND TO SITE CHECKSUM: B121440013 ONCOAIS ACTION: SEND TO SITE CHECKSUM: B7372604 ONCODSR ACTION: SEND TO SITE CHECKSUM: B91001573 ONCEDIT2 ACTION: SEND TO SITE CHECKSUM: B37770206 ONCGENED ACTION: SEND TO SITE CHECKSUM: B28576012 ONCOCFP1 ACTION: SEND TO SITE CHECKSUM: B85300341 ONCOPRT1 ACTION: SEND TO SITE CHECKSUM: B71270764 ONCACDU1 ACTION: SEND TO SITE CHECKSUM: B55925806 ONCNTX ACTION: SEND TO SITE CHECKSUM: B98533494 ONCUTX ACTION: SEND TO SITE CHECKSUM: B43786418 ONCCS2 ACTION: SEND TO SITE CHECKSUM: B114966999 ONCOCFL1 ACTION: SEND TO SITE CHECKSUM: B64672774 ONCOCOFA ACTION: SEND TO SITE CHECKSUM: B3650547 ONCOCOM ACTION: SEND TO SITE CHECKSUM: B69458933 ONCOEOD1 ACTION: SEND TO SITE CHECKSUM: B16414168
POST-INSTALL ROUTINE	ONC2PS10
PRE-INSTALL ROUTINE	PRE^ONC2PS10

ONC*2.2*10 (11590) BUILD (9.6)

ONC2.210 (11590) BUILD (9.6)